Atlas Trials

Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32)

Clinical trial NCT03296124 · WITHDRAWN

Trial details

NCT number
NCT03296124
Sponsor
University of Florida
Status
WITHDRAWN
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2017-12-07
Primary completion
2020-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.